Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16

2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37

3 Segmentation of Europe Market by Test 41
3.1 Market Overview by Test 41
3.2 Lipid Panel 43
3.3 Infectious Disease Testing 44
3.4 Liver Panel 45
3.5 Complete Blood Count (CBC) 46
3.6 Electrolyte Testing 47
3.7 Renal Panel 48
3.8 Other Tests 49

4 Segmentation of Europe Market by Product 50
4.1 Market Overview by Product 50
4.2 Instruments 52
4.3 Assay Kits & Reagents 53
4.4 Software & Services 54

5 Segmentation of Europe Market by Indication 55
5.1 Market Overview by Indication 55
5.2 Cardiovascular 57
5.3 Cancer 58
5.4 Infectious Disease 59
5.5 Stroke 60
5.6 Chronic Lower Respiratory Diseases 61
5.7 Diabetes 62
5.8 Other Indications 63

6 Segmentation of Europe Market by Patient Gender 64
6.1 Market Overview by Patient Gender 64
6.2 Male Patients 66
6.3 Female Patients 67

7 Segmentation of Europe Market by Age Group 68
7.1 Market Overview by Age Group 68
7.2 Age 44 and below 70
7.3 Age 45-64 71
7.4 Age 65 and over 72

8 Segmentation of Europe Market by End User 73
8.1 Market Overview by End User 73
8.2 Hospital & Clinics Laboratory 75
8.3 Diagnostic Laboratory 76
8.4 Point-of-Care Testing 77
8.5 Other End Users 78

9 European Market 2021-2031 by Country 79
9.1 Overview of European Market 79
9.2 Germany 82
9.3 U.K. 85
9.4 France 87
9.5 Spain 89
9.6 Italy 91
9.7 Russia 93
9.8 Rest of European Market 95

10 Competitive Landscape 97
10.1 Overview of Key Vendors 97
10.2 New Product Launch, Partnership, Investment, and M&A 100
10.3 Company Profiles 101
Abbott Laboratories 101
Becton, Dickinson and Company 103
BioMerieux SA 104
Bio-Rad Laboratories Inc. 105
Bio-Reference Laboratories 106
Bioscientia Healthcare 107
Charles River Laboratories 108
Danaher Corporation 109
Hoffmann-La Roche AG 110
Hologic Inc. 111
Qiagen NV 112
Siemens Healthcare 113
Thermo Fisher Scientific 114
RELATED REPORTS 115



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Europe Clinical Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Europe Clinical Diagnostics Market 24
Figure 7. Leading Causes of Death in the World, 2019-2020, million 27
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 10. Primary Restraints and Impact Factors of Europe Clinical Diagnostics Market 30
Figure 11. Investment Opportunity Analysis 34
Figure 12. Porter’s Fiver Forces Analysis of Europe Clinical Diagnostics Market 37
Figure 13. Breakdown of Europe Clinical Diagnostics Market by Test, 2021-2031, % of Revenue 42
Figure 14. Europe Addressable Market Cap in 2022-2031 by Test, Value ($ mn) and Share (%) 42
Figure 15. Europe Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, $ mn 43
Figure 16. Europe Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, $ mn 44
Figure 17. Europe Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, $ mn 45
Figure 18. Europe Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, $ mn 46
Figure 19. Europe Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, $ mn 47
Figure 20. Europe Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, $ mn 48
Figure 21. Europe Clinical Diagnostics Market by Test: Other Tests, 2021-2031, $ mn 49
Figure 22. Breakdown of Europe Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue 51
Figure 23. Europe Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 51
Figure 24. Europe Clinical Diagnostics Market by Product: Instruments, 2021-2031, $ mn 52
Figure 25. Europe Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, $ mn 53
Figure 26. Europe Clinical Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 54
Figure 27. Breakdown of Europe Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue 56
Figure 28. Europe Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 56
Figure 29. Europe Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, $ mn 57
Figure 30. Europe Clinical Diagnostics Market by Indication: Cancer, 2021-2031, $ mn 58
Figure 31. Europe Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, $ mn 59
Figure 32. Europe Clinical Diagnostics Market by Indication: Stroke, 2021-2031, $ mn 60
Figure 33. Europe Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, $ mn 61
Figure 34. Europe Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, $ mn 62
Figure 35. Europe Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, $ mn 63
Figure 36. Breakdown of Europe Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue 65
Figure 37. Europe Addressable Market Cap in 2022-2031 by Patient Gender, Value ($ mn) and Share (%) 65
Figure 38. Europe Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, $ mn 66
Figure 39. Europe Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, $ mn 67
Figure 40. Breakdown of Europe Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue 69
Figure 41. Europe Addressable Market Cap in 2022-2031 by Age Group, Value ($ mn) and Share (%) 69
Figure 42. Europe Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, $ mn 70
Figure 43. Europe Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, $ mn 71
Figure 44. Europe Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, $ mn 72
Figure 45. Breakdown of Europe Clinical Diagnostics Market by End User, 2021-2031, % of Revenue 73
Figure 46. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 74
Figure 47. Europe Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, $ mn 75
Figure 48. Europe Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, $ mn 76
Figure 49. Europe Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, $ mn 77
Figure 50. Europe Clinical Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 78
Figure 51. Breakdown of European Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 80
Figure 52. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 81
Figure 53. Clinical Diagnostics Market in Germany, 2021-2031, $ mn 82
Figure 54. Clinical Diagnostics Market in U.K., 2021-2031, $ mn 85
Figure 55. Clinical Diagnostics Market in France, 2021-2031, $ mn 87
Figure 56. Clinical Diagnostics Market in Spain, 2021-2031, $ mn 89
Figure 57. Clinical Diagnostics Market in Italy, 2021-2031, $ mn 91
Figure 58. Clinical Diagnostics Market in Russia, 2021-2031, $ mn 93
Figure 59. Clinical Diagnostics Market in Rest of Europe, 2021-2031, $ mn 95
Figure 60. Growth Stage of Europe Clinical Diagnostics Industry over the Forecast Period 97

List of Tables

List of Tables:

Table 1. Snapshot of Europe Clinical Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in Europe Clinical Diagnostics Market 33
Table 5. Europe Clinical Diagnostics Market by Test, 2021-2031, $ mn 41
Table 6. Europe Clinical Diagnostics Market by Product, 2021-2031, $ mn 50
Table 7. Europe Clinical Diagnostics Market by Indication, 2021-2031, $ mn 55
Table 8. Europe Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn 64
Table 9. Europe Clinical Diagnostics Market by Age Group, 2021-2031, $ mn 68
Table 10. Europe Clinical Diagnostics Market by End User, 2021-2031, $ mn 73
Table 11. Europe Clinical Diagnostics Market by Country, 2021-2031, $ mn 81
Table 12. Germany Clinical Diagnostics Market by Test, 2021-2031, $ mn 83
Table 13. Germany Clinical Diagnostics Market by Product, 2021-2031, $ mn 83
Table 14. Germany Clinical Diagnostics Market by Indication, 2021-2031, $ mn 83
Table 15. U.K. Clinical Diagnostics Market by Test, 2021-2031, $ mn 86
Table 16. U.K. Clinical Diagnostics Market by Product, 2021-2031, $ mn 86
Table 17. U.K. Clinical Diagnostics Market by Indication, 2021-2031, $ mn 86
Table 18. France Clinical Diagnostics Market by Test, 2021-2031, $ mn 88
Table 19. France Clinical Diagnostics Market by Product, 2021-2031, $ mn 88
Table 20. France Clinical Diagnostics Market by Indication, 2021-2031, $ mn 88
Table 21. Spain Clinical Diagnostics Market by Test, 2021-2031, $ mn 90
Table 22. Spain Clinical Diagnostics Market by Product, 2021-2031, $ mn 90
Table 23. Spain Clinical Diagnostics Market by Indication, 2021-2031, $ mn 90
Table 24. Italy Clinical Diagnostics Market by Test, 2021-2031, $ mn 92
Table 25. Italy Clinical Diagnostics Market by Product, 2021-2031, $ mn 92
Table 26. Italy Clinical Diagnostics Market by Indication, 2021-2031, $ mn 92
Table 27. Russia Clinical Diagnostics Market by Test, 2021-2031, $ mn 94
Table 28. Russia Clinical Diagnostics Market by Product, 2021-2031, $ mn 94
Table 29. Russia Clinical Diagnostics Market by Indication, 2021-2031, $ mn 94
Table 30. Clinical Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn 96
Table 31. Abbott Laboratories: Company Snapshot 101
Table 32. Abbott Laboratories: Business Segmentation 102
Table 33. Abbott Laboratories: Product Portfolio 102